| SKŘIČKOVÁ, Jana, Zbyněk BORTLÍČEK, Karel HEJDUK, Milos PEŠEK, Vitezslav KOLEK, Lucie KOUBKOVÁ, Marcela TOMÍŠKOVÁ, Jaromir ROUBEC, Libor HAVEL, Frantisek SALAJKA, Ivona GRYGARKOVA, Michal HRNCIARIK, Monika SATANKOVA, Zdenka POVOLNA, Marketa CERNOVSKA, Miroslav MAREL a Martina VASAKOVA. Gefitinib in front line treatment of patients with NSCLC in the Czech republic: Analysis of 113 patients. In ERS International Congress 2014. 2014. ISSN 1399-3003. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1205702,
author = {Skřičková, Jana and Bortlíček, Zbyněk and Hejduk, Karel and Pešek, Milos and Kolek, Vitezslav and Koubková, Lucie and Tomíšková, Marcela and Roubec, Jaromir and Havel, Libor and Salajka, Frantisek and Grygarkova, Ivona and Hrnciarik, Michal and Satankova, Monika and Povolna, Zdenka and Cernovska, Marketa and Marel, Miroslav and Vasakova, Martina},
booktitle = {ERS International Congress 2014},
keywords = {Gefitinib; NSCLC; EGFR mutation},
language = {eng},
title = {Gefitinib in front line treatment of patients with NSCLC in the Czech republic: Analysis of 113 patients},
year = {2014}
}
TY - CONF
ID - 1205702
AU - Skřičková, Jana - Bortlíček, Zbyněk - Hejduk, Karel - Pešek, Milos - Kolek, Vitezslav - Koubková, Lucie - Tomíšková, Marcela - Roubec, Jaromir - Havel, Libor - Salajka, Frantisek - Grygarkova, Ivona - Hrnciarik, Michal - Satankova, Monika - Povolna, Zdenka - Cernovska, Marketa - Marel, Miroslav - Vasakova, Martina
PY - 2014
TI - Gefitinib in front line treatment of patients with NSCLC in the Czech republic: Analysis of 113 patients
KW - Gefitinib
KW - NSCLC
KW - EGFR mutation
N2 - Gefitinib is the active and selective EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor). This study evaluates treatment outcomes in 113 NSCLC patients with activating EGFR mutation.
ER -
SKŘIČKOVÁ, Jana, Zbyněk BORTLÍČEK, Karel HEJDUK, Milos PEŠEK, Vitezslav KOLEK, Lucie KOUBKOVÁ, Marcela TOMÍŠKOVÁ, Jaromir ROUBEC, Libor HAVEL, Frantisek SALAJKA, Ivona GRYGARKOVA, Michal HRNCIARIK, Monika SATANKOVA, Zdenka POVOLNA, Marketa CERNOVSKA, Miroslav MAREL a Martina VASAKOVA. Gefitinib in front line treatment of patients with NSCLC in the Czech republic: Analysis of 113 patients. In \textit{ERS International Congress 2014}. 2014. ISSN~1399-3003.
|
